Tight junctions (TJs) are morphologically distinct and highly regulated areas of close contact between the plasma membranes of neighbouring epithelial and endothelial cells. They are the most apical component of the epithelial junctional complex (which also includes adherens junctions and desmosomes – see poster) and are connected to the actin cytoskeleton. In freeze-fracture electron microscopy, TJs appear as intramembrane strands that form a net-like meshwork that encircles cells (see poster). TJs contribute to the formation of polarised epithelial and endothelial barriers by controlling the extent and selectivity of diffusion along the paracellular pathway (the gate function) and by forming an apical/basolateral intramembrane diffusion barrier in the outer leaflet of the plasma membrane (the fence function) (Cereijido et al., 2008). Exciting research in recent years has also linked TJs to intracellular signalling mechanisms that guide epithelial-cell proliferation, polarisation and differentiation. Several types of protein components of TJs have been identified, and these have revealed a basic architectural principle in which transmembrane proteins are linked to a cytoplasmic plaque that is formed by a network of scaffolding and adaptor proteins, signalling components and actin-binding cytoskeletal linkers (see poster). Recent work into the cellular functions of these proteins has started to reveal how TJs are formed and which of their components contribute to their characteristic morphological appearance, as well as how they are regulated and how they signal to regulate changes in epithelial cells. Moreover, defects in TJ components, as well as dysregulation of their expression, contribute to inherited diseases and to cancer, and several TJ proteins are targeted by viruses, bacteria and other pathogens. This suggests that TJ-associated processes have an important role in the pathogenesis of a wide range of diseases. Here, we give a brief review of some of the recently described components of TJs, and discuss how they are thought to contribute to TJ structure and function.FIG1 

Transmembrane proteins

TJs contain two principal types of transmembrane components – tetraspan and single-span transmembrane proteins. The tetraspan proteins are occludin, tricellulin and the claudins, all of which are associated with the junctional intramembrane strands described above and are thought to have the same membrane topology (both the N- and C-termini in the cytosol). Tetraspan proteins form the paracellular permeability barrier and determine the capacity and the selectivity of the paracellular diffusion pathway (see below).

Claudins

The claudins, which constitute a family of at least 24 members, are expressed in a tissue-specific manner. They are thought to be the main structural components of intramembrane strands (Furuse and Tsukita, 2006). The claudin composition of a junction determines the ion selectivity of the paracellular pathway, because changes in claudin expression correlate with alterations in conductivity for specific ions. Via their C-terminal cytoplasmic domains, claudins interact with several PSD95–DlgA–ZO-1 homology (PDZ)-domain-containing cytosolic proteins and these interactions are thought to be important for junction assembly. The extracellular loops of claudins have been proposed to create charge-selective paracellular aqueous pores that permit the passive diffusion of ions between cells (Krause et al., 2008; Van Itallie and Anderson, 2006); however, structural evidence for such pores is still missing and it is not clear how the extracellular domains of different claudin molecules cooperate to assemble continuous, ion-conductive pores.

Occludin

Similar to the claudins, occludin is associated with intramembrane strands, although it is not required for their assembly. It regulates the paracellular diffusion of small hydrophilic molecules, has been linked to the formation of the intramembrane diffusion barrier and regulates the transepithelial migration of neutrophils (Aijaz et al., 2006). Either one of its N- and C-terminal cytosolic domains is sufficient to anchor the protein in the junction and to ensure a continuous junctional distribution. Although both domains interact with components of the cytosolic plaque, they have different functional properties – the N-terminal domain regulates neutrophil transmigration and the C-terminal domain regulates the paracellular diffusion of small hydrophilic tracers as well as targeting of occludin to the basolateral membrane. Similarly, the two extracellular loops of occludin regulate its accumulation at junctions as well as paracellular permeability. Occludin has also been linked to the regulation of various subcellular signalling pathways, such as MAP-kinase-dependent pathways and RhoA signalling. In the case of the regulation of Raf1 and TGFβ, this signalling function involves the second (more C-terminal) extracellular domain (Barrios-Rodiles et al., 2005; Wang et al., 2005; Yu et al., 2005). However, the underlying molecular mechanisms of many of the processes to which occludin has been linked remain to be determined and the functional relevance of most of its biochemical interactions is still unknown.

Tricellulin

Tricellulin was first identified as a protein that is downregulated by the zinc-finger transcription factor Snail (Ikenouchi et al., 2005). In contrast to occludin and the claudins, tricellulin is enriched at the junctions between three epithelial cells. The suppression of tricellulin expression by RNA interference impairs the barrier function of TJs, which suggests that it is required for junction formation (Ikenouchi et al., 2005). In its C-terminal cytoplasmic domain, tricellulin shares a conserved domain with occludin that mediates binding to the tight junction protein 1 (TJP1, hereafter referred to as ZO-1), a cytosolic component of TJs (see below) (Riazuddin et al., 2006). Although this domain is affected in mutations that cause deafness, the role of the interaction of tricellulin with ZO-1 in the formation of junctions is unknown.

Single-span transmembrane proteins

Most of the single-span transmembrane proteins that are associated with TJs, including the junctional adhesion molecules (JAMs), are members of the CTX/VH-C2 family of adhesion proteins. These proteins contain two immunoglobulin folds in their extracellular domain, one of the VH- and one of the C2-type (Bazzoni, 2003). Four JAMs – JAM-A, -B, -C and -D – have been identified, and all four can mediate homotypic cell-cell adhesion. Several of the JAM proteins, as well as the related proteins coxsackievirus and adenovirus receptor (CAR), CAR-like membrane protein (CLMP) and the endothelial-cell-selective adhesion molecule (ESAM), associate with TJs and interact with adaptor proteins of the cytoplasmic plaque (Bazzoni et al., 2000; Ebnet et al., 2003; Ebnet et al., 2000; Raschperger et al., 2004; Wegmann et al., 2004). JAMs regulate adhesion between leukocytes and endothelial cells, as well as the paracellular transmigration of leukocytes across the endothelium, and have been shown to regulate the development of cell polarity by binding to the evolutionarily conserved complex between PAR3, PAR6 and atypical PKC (aPKC) (Bradfield et al., 2007; Ebnet et al., 2004; Weber et al., 2007). The role of JAMs in cell polarisation is also important during spermatogenesis, because JAM-C-deficient spermatids fail to polarise and differentiate.

Another type of single-span membrane protein that is associated with TJs is Crumbs homologue 3 (CRB3), one of the three vertebrate homologues of the Drosophila melanogaster protein Crumbs (Lemmers et al., 2004; Makarova et al., 2003; Roh et al., 2003). CRB3 is present across the entire apical membrane and only a minor fraction of the entire cellular pool is associated with TJs. The cytoplasmic domain of CRB3 interacts with cytosolic adaptor proteins such as Pals1, which link it to the cellular machinery that regulates epithelial polarisation (Hurd et al., 2003; Lemmers et al., 2004). Consequently, the overexpression of CRB3 leads to delayed TJ formation in monolayers of Madin-Darby canine kidney (MDCK) cells and to disruption of epithelial morphogenesis. CRB3 also localises to the primary cilium and regulates ciliary morphogenesis (Fan et al., 2007).

Finally, Bves (a member of the Popeye-domain-containing family of transmembrane proteins), also localises to TJs in polarised epithelia and associates with ZO-1-based complexes (see below) (Osler et al., 2005). The downregulation of Bves in cultured cells reduces transepithelial resistance and junctional protein localisation at the membrane, which suggests that Bves contributes to the establishment and/or maintenance of epithelial integrity (Osler et al., 2005); however, the role of Bves in TJs is poorly understood and little is known about its interaction partners.

The cytoplasmic plaque

Intercellular junctions have similar building principles in different cell types and often share components. For example, many of the components that are associated with epithelial junctions are also found at neuronal synapses (Yamada and Nelson, 2007). These components often have similar functions, such as the regulation of the cytoskeleton to guide the assembly and disassembly of the junction or synapse. A major structural feature of junctions is that they contain a cytoplasmic plaque, which forms an interface between the junctional membrane and the cytoskeleton. In TJs, the cytoplasmic plaque functions in the regulation of adhesion and paracellular permeability, as well as in the transmission of signals from the junction to the cell interior to regulate cellular processes such as migration and gene expression. The cytoplasmic plaque is formed by a complex network of adaptors, scaffolding and cytoskeletal proteins that crosslink junctional membrane proteins and connect TJs to the actin cytoskeleton (see poster). The TJ plaque also recruits an array of signalling components that includes classical signalling proteins, such as kinases and phosphatases, as well as dual-localisation proteins that can reside at junctions as well as in the nucleus and provide a mechanism by which TJs can regulate gene expression (Guillemot et al., 2008; Matter and Balda, 2007; Paris et al., 2008).

ZO-1, the first TJ protein to be identified, is one of the most-studied TJ plaque components. It has the typical functional properties and domain structure of a scaffolding protein – it contains several protein-protein interaction domains, including three PDZ domains, one SH3 domain and one guanylate kinase homology (GUK) domain), as well as an F-actin-binding domain. ZO-1 interacts with claudins through its first PDZ domain, with ZO-2 or ZO-3 (two other TJ adaptors of the same protein family as ZO-1) through its second PDZ domain, with occludin through the GUK domain, and with actin and α-catenin through its large C-terminal domain (Fanning, 2001; Umeda et al., 2006). In addition, ZO-1 binds through its SH3 domain to several signalling proteins such as a serine/threonine protein kinase, the Y-box transcription factor ZONAB and the heat-shock protein Apg2, as well as Gα12, an α subunit of heterotrimeric G proteins (Matter and Balda, 2007; Meyer et al., 2002). These interaction partners can regulate each other; for example, Apg2 regulates the interaction between ZO-1 and ZONAB during the heat-shock response, which results in the nuclear accumulation and activation of ZONAB.

Other junctional proteins are present as components of evolutionarily conserved signalling complexes, which are based on the adaptors PAR3 and PAR6, or Pals1 and PATJ (Assemat et al., 2007; Wang and Margolis, 2007). Both of these complexes are found in both vertebrates and invertebrates and are crucial for the development of cell polarity and for epithelial morphogenesis. Both complexes bind to TJ membrane proteins: the PAR3-PAR6 complex binds to JAMs and the Pals1-PATJ complex binds to CRB3. The complexes are not independent but, instead interact with each other. For example, PAR6 also binds to Pals1 and CRB3 (Hurd et al., 2003; Lemmers et al., 2004), and ZO-3 – an interaction partner of ZO-1 – binds to PATJ (Michel et al., 2005; Roh et al., 2002). However, in most cases in which such interactions between components of different complexes have been identified, it has not yet been determined how common such interactions are and how they contribute to junction assembly and function.

The classical functions of TJs are the regulation of paracellular permeability and the formation of an apical-basolateral intramembrane diffusion barrier that helps to maintain cell-surface polarity. More recently, TJs have been linked to various signalling mechanisms that guide gene expression, proliferation and differentiation. TJ components also form complexes with the cellular machinery that regulates basolateral cell-surface transport (the Sec6-Sec8 complex); however, this does not appear to be an exclusive property of TJ proteins because these complexes also contain adherens-junction components, such as E-cadherin and nectin 2 (Yeaman et al., 2004). The actual structure that forms the intramembrane diffusion barrier is poorly understood; hence, we limit our discussion to the role of TJs in the regulation of paracellular permeability, as well as in signalling during epithelial proliferation and differentiation.

Paracellular permeability

TJs allow the passive selective diffusion of ions and small hydrophilic molecules through the paracellular pathway across epithelia and endothelia. The molecular mechanisms that are responsible for selective ion permeability and for diffusion of small hydrophilic molecules are distinct, as many manipulations and regulatory mechanisms specifically affect only one of the two processes, or downregulate one while activating the other (Aijaz et al., 2006). For example, the overexpression of occludin or certain occludin mutants in cultured epithelial cells stimulates the paracellular diffusion of small hydrophilic molecules but increases transepithelial electrical resistance (a measure of transepithelial ion permeability) (Aijaz et al., 2006).

Occludin, tricellulin and the claudins are the main TJ membrane components that are involved in paracellular permeability. On the basis of observations in human disease, mouse models and cultured cell lines, it has been suggested that the claudin composition of TJs is a major determinant of the permeability properties of a tissue (Furuse and Tsukita, 2006; Van Itallie and Anderson, 2006). Absence of specific claudins can cause organ-specific defects, such as neurological, reproductive and renal defects. For example, mice that lack claudin 1 die after birth because of water loss across the skin, and the absence of claudin 5 causes leakage of small tracers across the brain endothelium (Furuse and Tsukita, 2006). Experiments with epithelial cell lines further suggest that different claudins favour paracellular diffusion of specific ions and, as mentioned above, these have lead to a model in which claudins form homo- and hetero-oligomers that engage in intercellular interactions to form paracellular aqueous pores. The ion-selectivity of these pores is determined by their claudin composition (Krause et al., 2008; Van Itallie and Anderson, 2006).

The process that mediates the paracellular diffusion of small hydrophilic molecules is less well understood and the actual mechanism by which such molecules permeate the junction is not known. However, the process is regulated by RhoA signalling and seems to require actinomyosin-driven processes (Aijaz et al., 2006; McKenzie and Ridley, 2007; Nusrat et al., 2000; Utech et al., 2006). It is therefore possible that dynamic rearrangements of intramembrane strands lead to paracellular diffusion. Occludin has been linked to the regulation of paracellular permeability of small hydrophilic molecules across cultured epithelial monolayers (Balda and Matter, 2000; Schneeberger and Lynch, 2004); it is thought that this regulatory mechanism involves phosphorylation events as well as the actin cytoskeleton because the C-terminal domain of occludin binds to protein kinases and lipid kinases, as well as to actin filaments and cytoskeletal linkers (Aijaz et al., 2006; Schneeberger and Lynch, 2004). Strikingly, live-cell-imaging experiments using GFP-tagged occludin have recently suggested that occludin diffuses within the junction, suggesting that occludin dynamics might contribute to paracellular diffusion (Shen et al., 2008). However, because the experiment involved an N-terminal GFP-tag and blocking the N-terminus is known to interfere with anchoring of occludin within the junction, it is not clear whether the observed dynamic properties indeed reflect physiological occludin behaviour (Huber et al., 2000).

Cell proliferation, polarity and differentiation

The regulation of cell proliferation and polarisation is crucial for the development of differentiated tissues. Several studies have linked TJs to the regulation of cell proliferation and cell polarity. Similar to adherens junctions, TJs function in the suppression of proliferation (Gonzalez-Mariscal et al., 2007; Matter and Balda, 2007). Occludin suppresses oncogenic Raf-1 signalling (Wang et al., 2005) and ZO-1 interacts with ZONAB, thereby regulating gene expression, cell proliferation and epithelial morphogenesis (Matter and Balda, 2007; Sourisseau et al., 2006). ZO-2 localises to the nucleus and interacts with the DNA-binding protein scaffold attachment factor B (SAFB) as well as with several transcription factors (Gonzalez-Mariscal et al., 2007; Huerta et al., 2007; Traweger et al., 2003). TJs have also been linked to the regulation of RhoA-dependent proliferation through the junction-associated guanine-nucleotide exchange factor GEF-H1 and the junctional scaffolding protein cingulin, which binds to and inhibits GEF-H1 (Aijaz et al., 2005; Guillemot and Citi, 2006). It remains to be determined, however, whether and how these different TJ-associated signalling mechanisms are connected with each other and by which transmembrane proteins they are regulated. Strikingly, deficiencies in ZO-1 or ZO-2 expression are embryonic lethal in mice, which suggests that the two TJ proteins are important for development (Katsuno et al., 2008; Xu et al., 2008). Whether any of the signalling mechanisms that have been identified in cell culture experiments contribute to these phenotypes in vivo, however, is not clear.

Two evolutionarily conserved cell-polarity signalling pathways reside at TJs. Similar to D. melanogaster, the CRB3-Pals1-PATJ pathway regulates junction assembly and biogenesis of the apical membrane in vertebrate epithelial cells (Shin et al., 2006). The signalling pathway downstream of the complex has not yet been elucidated. The second conserved signalling module is the PAR3-PAR6-aPKC complex, which was originally described as a regulator of cytoplasmic partitioning in the early embryo of Caenorhabditis elegans. PAR3 associates with the cytoplasmic domain of JAMs, which results in the recruitment of the PAR3-PAR6-aPKC complex to cell-cell junctions (Bradfield et al., 2007; Ebnet et al., 2004; Weber et al., 2007). The complex functions as an effector of Cdc42, a Rho-family GTPase that is essential for epithelial-cell polarity and becomes activated during junction formation – binding of the complex to GTP-bound Cdc42 stimulates activation of aPKC and, consequently, the formation of mature TJs (Ebnet et al., 2004; Shin et al., 2006). In agreement with these observations, Cdc42 is crucial for the establishment of epithelial polarity during early mammalian development, and the aPKC isoforms PAR3 and PAR6 are necessary for the formation of the epidermal barrier (Helfrich et al., 2007; Wu et al., 2007). Interestingly, PAR3 also suppresses the activation of Rac1, another member of the RhoGTPase family, during junction formation by binding the guanine nucleotide exchange factor TIAM1 (Chen and Macara, 2005). This function, however, does not require PAR6 or aPKC, which suggests that PAR3 can act independently of PAR6 and aPKC.

Defects in permeability

TJ transmembrane proteins are affected in several inherited diseases, which suggests that the selectivity of the junctional diffusion barrier is physiologically important. For example, mutations in claudin 16 (which was originally called paracellin-1) and claudin 19 cause hypomagnesaemia (renal magnesium wasting) owing to a deficiency in paracellular magnesium resorption in the kidney (Konrad et al., 2006; Simon et al., 1999). The two proteins interact and are thought to form a paracellular cation pore. Similarly, mutations in claudin 14 and tricellulin cause hereditary deafness, which is likely to be the result of alterations in paracellular permeability (Riazuddin et al., 2006; Wilcox et al., 2001).

The WNK (with-no-K[Lys]) kinases WNK4 and WNK1, mutations in which cause hypertension (pseudohypo-aldosteronism type II) because of their effects on renal salt reabsorption and K+ excretion (Wilson et al., 2001), are also thought to act through claudins. Disease is caused by WNK4 alleles that have gain-of-function mutations and therefore hyperstimulate claudin phosphorylation, which results in increased paracellular Cl permeability and, subsequently, hypertension (Kahle et al., 2004; Yamauchi et al., 2004; Richardson and Alessi, 2008).

The expression of several TJ components is affected in various carcinomas. For example, the expression levels of ZO-1 and ZO-2 are dysregulated in different types of cancers and, in the case of breast cancer, low expression of ZO-1 has been correlated with a poor prognosis (Chlenski et al., 2000; Chlenski et al., 1999; Hoover et al., 1998; Kleeff et al., 2001; Martin et al., 2004; Morita et al., 2004; Resnick et al., 2005; Takai et al., 2005). Similarly, several junctional scaffolding proteins are bound and inactivated by viral oncogenes (Glaunsinger et al., 2001; Latorre et al., 2005). By contrast, ZONAB and its activating protein Apg2 are both upregulated in hepatocellular carcinomas, which suggests that this proliferation-promoting pathway is stimulated (Arakawa et al., 2004; Gotoh et al., 2004; Hayashi et al., 2002).

To what extent these alterations are a cause or a consequence of carcinogenesis is generally not clear. Nevertheless, claudin 1 has been shown to promote transformation and metastatic behaviour in colon cancer (Dhawan et al., 2005). The underlying molecular mechanism by which claudin 1 regulates migration is not clear. However, it might involve the association of claudin 1 with integrin-based complexes, similar to the role of claudin 11 in cell migration (Tiwari-Woodruff et al., 2001).

TJ proteins as targets of pathogens

TJ proteins are targeted by several types of pathogens, and these interactions often lead to junctional dissociation and the loss of epithelial barrier function. For example, proteolytic enzymes from pollen and dust mites, as well as enterotoxin from Clostridium perfringens, attack junctional membrane proteins, which results in paracellular leakage (Runswick et al., 2007; Sonoda et al., 1999; Wan et al., 1999). In addition, several TJ transmembrane proteins function as receptors for viruses. For example, claudin 1 functions as a co-receptor for the hepatitis C virus and is required for virus entry (Evans et al., 2007). Similarly, several of the TJ-associated members of the CTX-protein family, such as the coxsackievirus and adenovirus receptor (CAR) and JAM-A (which binds to reovirus), also act as viral receptors (Barton et al., 2001; Cohen et al., 2001; Walters et al., 2002). In some cases (e.g. hepatitis C virus), binding of virus to the TJ protein favours its entry into cells, whereas in other cases the interaction helps to overcome the junctional diffusion barrier to enable the virus to access its actual receptor (e.g. rotavirus) or to promote the release of virus from the epithelium (e.g. adenovirus) (Evans et al., 2007; Nava et al., 2004; Walters et al., 2002). Another striking example is provided by the bacterium Helicobacter pylori, which causes gastric ulcers and cancer (Pritchard and Crabtree, 2006). H. pylori translocates a protein called CagA into host cells. CagA associates with the ZO-1–JAM-A complex, which is thought to contribute to corruption of the gastric epithelial barrier (Amieva et al., 2003). Because the binding of CagA causes the redistribution of ZO-1 complexes, it is possible that ZO-1-associated signalling mechanisms contribute to the development of H. pylori-induced pathologies.

A complex network of TJ-associated proteins has been identified over the last 20 years. Despite this, we have only begun to understand how these proteins interact with each other and cooperate to perform various junctional functions. Thus, the identification of specific TJ-associated molecular mechanisms remains a major challenge for the future. For example, many junctional proteins can bind to several other proteins and it seems unlikely that they associate with all of them at once; it will therefore be important to identify the role of particular interactions for junction assembly, and to determine when they occur and for which functions of TJs they are important. Moreover, substantial evidence indicates the existence of mechanisms that permit the paracellular permeation of specific ions and small hydrophilic molecules; however, the underlying molecular structure and machinery are only poorly understood and there is little structural information. Only a few animal models that are deficient in specific TJ proteins have thus far been generated and most have not been analysed in great detail. Moreover, TJ junctions will have to be studied in different species in the future, because the example of ZO-3 has shown that deficiency of a specific protein can lead to different phenotypes in different animal models (Adachi et al., 2006; Kiener et al., 2008; Xu et al., 2008). To understand the role of TJ-associated signalling mechanisms and junctional barrier properties, it will be crucial to determine the role of TJ-associated proteins in development and their importance for normal organ function. Finally, TJ proteins appear to contribute to many diseases, ranging from viral infections to cancer. The understanding of TJs at a molecular level, and of how they contribute to such diseases, should provide therapeutic opportunities for a wide range of disorders.

We apologise to anyone whose work and publications could not be cited due to the limited available space. M.S.B. and K.M. are supported by the Medical Research Council, the Biotechnology and Biological Sciences Research Council, the Association for International Cancer Research, Fight for Sight and the Wellcome Trust. The electron micrograph of the junctional complex in kidney epithelial cells is reprinted from Huber et al. (Huber et al., 1998), with permission. The electron microscopic image of a freeze-fracture replica from intestinal epithelial cells was kindly provided by Peter Munro, UCL Institute of Ophthalmology, London, UK.

Adachi, M., Inoko, A., Hata, M., Furuse, K., Umeda, K., Itoh, M. and Tsukita, S. (
2006
). Normal establishment of epithelial tight junctions in mice and cultured cells lacking expression of ZO-3, a tight-junction MAGUK protein.
Mol. Cell. Biol.
26
,
9003
-9015.
Aijaz, S., D'Atri, F., Citi, S., Balda, M. S. and Matter, K. (
2005
). Binding of GEF-H1 to the tight junction-associated adaptor cingulin results in inhibition of Rho signaling and G1/S phase transition.
Dev. Cell
8
,
777
-786.
Aijaz, S., Balda, M. S. and Matter, K. (
2006
). Tight junctions: molecular architecture and function.
Int. Rev. Cytol.
248
,
261
-298.
Amieva, M. R., Vogelmann, R., Covacci, A., Tompkins, L. S., Nelson, W. J. and Falkow, S. (
2003
). Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA.
Science
300
,
1430
-1434.
Arakawa, Y., Kajino, K., Kano, S., Tobita, H., Hayashi, J., Yasen, M., Moriyama, M. and Hino, O. (
2004
). Transcription of dbpA, a Y box binding protein, is positively regulated by E2F1: implications in hepatocarcinogenesis.
Biochem. Biophys. Res. Commun.
322
,
297
-302.
Assemat, E., Bazellieres, E., Pallesi-Pocachard, E., Le Bivic, A. and Massey-Harroche, D. (
2007
). Polarity complex proteins.
Biochim Biophys Acta
.
1778
,
614
-630.
Balda, M. S. and Matter, K. (
2000
). Transmembrane proteins of tight junctions.
Sem. Cell Dev. Biol.
11
,
281
-289.
Barrios-Rodiles, M., Brown, K. R., Ozdamar, B., Bose, R., Liu, Z., Donovan, R. S., Shinjo, F., Liu, Y., Dembowy, J., Taylor, I. W. et al. (
2005
). High-throughput mapping of a dynamic signaling network in mammalian cells.
Science
307
,
1621
-1625.
Barton, E. S., Forrest, J. C., Connolly, J. L., Chappell, J. D., Liu, Y., Schnell, F. J., Nusrat, A., Parkos, C. A. and Dermody, T. S. (
2001
). Junction adhesion molecule is a receptor for reovirus.
Cell
104
,
441
-451.
Bazzoni, G. (
2003
). The JAM family of junctional adhesion molecules.
Curr. Opin. Cell Biol.
15
,
525
-530.
Bazzoni, G., Martinez-Estrada, O. M., Orsenigo, F., Cordenonsi, M., Citi, S. and Dejana, E. (
2000
). Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin.
J. Biol. Chem.
275
,
20520
-20526.
Bradfield, P. F., Nourshargh, S., Aurrand-Lions, M. and Imhof, B. A. (
2007
). JAM family and related proteins in leukocyte migration (Vestweber series).
Arterioscler. Thromb. Vasc. Biol.
27
,
2104
-2112.
Cereijido, M., Contreras, R. G., Shoshani, L., Flores-Benitez, D. and Larre, I. (
2008
). Tight junction and polarity interaction in the transporting epithelial phenotype.
Biochim. Biophys. Acta
1778
,
770
-793.
Chen, X. and Macara, I. G. (
2005
). Par-3 controls tight junction assembly through the Rac exchange factor Tiam1.
Nat. Cell Biol.
7
,
262
-269.
Chlenski, A., Ketels, K. V., Tsao, M. S., Talamonti, M. S., Anderson, M. R., Oyasu, R. and Scarpelli, D. G. (
1999
). Tight junction protein ZO-2 is differentially expressed in normal pancreatic ducts compared to human pancreatic adenocarcinoma.
Int. J. Cancer
82
,
137
-144.
Chlenski, A., Ketels, K. V., Korovaitseva, G. I., Talamonti, M. S., Oyasu, R. and Scarpelli, D. G. (
2000
). Organization and expression of the human zo-2 gene (tjp-2) in normal and neoplastic tissues.
Biochim. Biophys. Acta
1493
,
319
-324.
Cohen, C. J., Shieh, J. T., Pickles, R. J., Okegawa, T., Hsieh, J. T. and Bergelson, J. M. (
2001
). The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction.
Proc. Natl. Acad. Sci. USA
98
,
15191
-15196.
Dhawan, P., Singh, A. B., Deane, N. G., No, Y., Shiou, S. R., Schmidt, C., Neff, J., Washington, M. K. and Beauchamp, R. D. (
2005
). Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer.
J. Clin. Invest.
115
,
1765
-1776.
Ebnet, K., Schulz, C. U., Meyer Zu Brickwedde, M. K., Pendl, G. G. and Vestweber, D. (
2000
). Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1.
J. Biol. Chem.
275
,
27979
-27988.
Ebnet, K., Aurrand-Lions, M., Kuhn, A., Kiefer, F., Butz, S., Zander, K., Meyer zu Brickwedde, M. K., Suzuki, A., Imhof, B. A. and Vestweber, D. (
2003
). The junctional adhesion molecule (JAM) family members JAM-2 and JAM-3 associate with the cell polarity protein PAR-3: a possible role for JAMs in endothelial cell polarity.
J. Cell Sci.
116
,
3879
-3891.
Ebnet, K., Suzuki, A., Ohno, S. and Vestweber, D. (
2004
). Junctional adhesion molecules (JAMs): more molecules with dual functions?
J. Cell Sci.
117
,
19
-29.
Evans, M. J., von Hahn, T., Tscherne, D. M., Syder, A. J., Panis, M., Wolk, B., Hatziioannou, T., McKeating, J. A., Bieniasz, P. D. and Rice, C. M. (
2007
). Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry.
Nature
446
,
801
-805.
Fan, S., Fogg, V., Wang, Q., Chen, X. W., Liu, C. J. and Margolis, B. (
2007
). A novel Crumbs3 isoform regulates cell division and ciliogenesis via importin beta interactions.
J. Cell Biol.
178
,
387
-398.
Fanning, A. S. (
2001
). Organization and the regulation of the tight junction by the actin-myosin cytoskeleton. In
Tight Junctions
(ed. J. M. Anderson and M. Cereijido), pp.
265
-284. Boca Raton, FL: CRC Press.
Furuse, M. and Tsukita, S. (
2006
). Claudins in occluding junctions of humans and flies.
Trends Cell Biol.
16
,
181
-188.
Glaunsinger, B. A., Weiss, R. S., Lee, S. S. and Javier, R. (
2001
). Link of the unique oncogenic properties of adenovirus type 9 E4-ORF1 to a select interaction with the candidate tumor suppressor protein ZO-2.
EMBO J.
20
,
5578
-5586.
Gonzalez-Mariscal, L., Lechuga, S. and Garay, E. (
2007
). Role of tight junctions in cell proliferation and cancer.
Prog. Histochem. Cytochem.
42
,
1
-57.
Gotoh, K., Nonoguchi, K., Higashitsuji, H., Kaneko, Y., Sakurai, T., Sumitomo, Y., Itoh, K., Subjeck, J. R. and Fujita, J. (
2004
). Apg-2 has a chaperone-like activity similar to Hsp110 and is overexpressed in hepatocellular carcinomas.
FEBS Lett.
560
,
19
-24.
Guillemot, L. and Citi, S. (
2006
). Cingulin regulates claudin-2 expression and cell proliferation through the small GTPase RhoA.
Mol. Biol. Cell
17
,
3569
-3577.
Guillemot, L., Paschoud, S., Pulimeno, P., Foglia, A. and Citi, S. (
2008
). The cytoplasmic plaque of tight junctions: a scaffolding and signalling center.
Biochim. Biophys. Acta
1778
,
601
-613.
Hayashi, J., Kajino, K., Umeda, T., Takano, S., Arakawa, Y., Kudo, M. and Hino, O. (
2002
). Somatic mutation and SNP in the promoter of dbpA and human hepatocarcinogenesis.
Int. J. Oncol.
21
,
847
-850.
Helfrich, I., Schmitz, A., Zigrino, P., Michels, C., Haase, I., le Bivic, A., Leitges, M. and Niessen, C. M. (
2007
). Role of aPKC isoforms and their binding partners Par3 and Par6 in epidermal barrier formation.
J. Invest. Dermatol.
127
,
782
-791.
Hoover, K. B., Liao, S. Y. and Bryant, P. J. (
1998
). Loss of the tight junction MAGUK ZO-1 in breast cancer: relationship to glandular differentiation and loss of heterozygosity.
Am. J. Pathol.
153
,
1767
-1773.
Huber, D., Balda, M. S. and Matter, K. (
1998
). Transepithelial migration of neutrophils.
Invasion Metastasis
18
,
70
-80.
Huber, D., Balda, M. S. and Matter, K. (
2000
). Occludin modulates transepithelial migration of neutrophils.
J. Biol. Chem.
275
,
5773
-5778.
Huerta, M., Munoz, R., Tapia, R., Soto-Reyes, E., Ramirez, L., Recillas-Targa, F., Gonzalez-Mariscal, L. and Lopez-Bayghen, E. (
2007
). Cyclin D1 is transcriptionally down-regulated by ZO-2 via an E box and the transcription factor c-Myc.
Mol. Biol. Cell
18
,
4826
-4836.
Hurd, T. W., Gao, L., Roh, M. H., Macara, I. G. and Margolis, B. (
2003
). Direct interaction of two polarity complexes implicated in epithelial tight junction assembly.
Nat. Cell Biol.
5
,
137
-142.
Ikenouchi, J., Furuse, M., Furuse, K., Sasaki, H. and Tsukita, S. (
2005
). Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells.
J. Cell Biol.
171
,
939
-945.
Kahle, K. T., Macgregor, G. G., Wilson, F. H., Van Hoek, A. N., Brown, D., Ardito, T., Kashgarian, M., Giebisch, G., Hebert, S. C., Boulpaep, E. L. et al. (
2004
). Paracellular Cl-permeability is regulated by WNK4 kinase: insight into normal physiology and hypertension.
Proc. Natl. Acad. Sci. USA
101
,
14877
-14882.
Katsuno, T., Umeda, K., Matsui, T., Hata, M., Tamura, A., Itoh, M., Takeuchi, K., Fujimori, T., Nabeshima, Y. I., Noda, T. et al. (
2008
). Deficiency of ZO-1 causes embryonic lethal phenotype associated with defected yolk sac angiogenesis and apoptosis of embryonic cells.
Mol. Biol. Cell
19
,
2465
-2475.
Kiener, T. K., Selptsova-Friedrich, I. and Hunziker, W. (
2008
). Tjp3/zo-3 is critical for epidermal barrier function in zebrafish embryos.
Dev. Biol.
316
,
36
-49.
Kleeff, J., Shi, X., Bode, H. P., Hoover, K., Shrikhande, S., Bryant, P. J., Korc, M., Buchler, M. W. and Friess, H. (
2001
). Altered expression and localization of the tight junction protein ZO-1 in primary and metastatic pancreatic cancer.
Pancreas
23
,
259
-265.
Konrad, M., Schaller, A., Seelow, D., Pandey, A. V., Waldegger, S., Lesslauer, A., Vitzthum, H., Suzuki, Y., Luk, J. M., Becker, C. et al. (
2006
). Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement.
Am. J. Hum. Genet.
79
,
949
-957.
Krause, G., Winkler, L., Mueller, S. L., Haseloff, R. F., Piontek, J. and Blasig, I. E. (
2008
). Structure and function of claudins.
Biochim Biophys Acta
1778
,
631
-645.
Latorre, I. J., Roh, M. H., Frese, K. K., Weiss, R. S., Margolis, B. and Javier, R. T. (
2005
). Viral oncoprotein-induced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cells.
J. Cell Sci.
118
,
4283
-4293.
Lemmers, C., Michel, D., Lane-Guermonprez, L., Delgrossi, M. H., Medina, E., Arsanto, J. P. and Le Bivic, A. (
2004
). CRB3 binds directly to Par6 and regulates the morphogenesis of the tight junctions in mammalian epithelial cells.
Mol. Biol. Cell
15
,
1324
-1333.
Makarova, O., Roh, M. H., Liu, C. J., Laurinec, S. and Margolis, B. (
2003
). Mammalian Crumbs3 is a small transmembrane protein linked to protein associated with Lin-7 (Pals1).
Gene
302
,
21
-29.
Martin, T. A., Watkins, G., Mansel, R. E. and Jiang, W. G. (
2004
). Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer.
Eur. J. Cancer
40
,
2717
-2725.
Matter, K. and Balda, M. S. (
2007
). Tight junctions, gene expression and nucleo-junctinal interplay.
J. Cell Sci.
120
,
1505
-1511.
McKenzie, J. A. and Ridley, A. J. (
2007
). Roles of Rho/ROCK and MLCK in TNF-alpha-induced changes in endothelial morphology and permeability.
J. Cell Physiol
.
213
,
221
-228.
Meyer, T. N., Schwesinger, C. and Denker, B. M. (
2002
). Zonula occludens-1 is a scaffolding protein for signaling molecules. Galpha(12) directly binds to the Src homology 3 domain and regulates paracellular permeability in epithelial cells.
J. Biol. Chem.
277
,
24855
-24858.
Michel, D., Arsanto, J. P., Massey-Harroche, D., Beclin, C., Wijnholds, J. and Le Bivic, A. (
2005
). PATJ connects and stabilizes apical and lateral components of tight junctions in human intestinal cells.
J. Cell Sci.
118
,
4049
-4057.
Morita, K., Tsukita, S. and Miyachi, Y. (
2004
). Tight junction-associated proteins (occludin, ZO-1, claudin-1, claudin-4) in squamous cell carcinoma and Bowen's disease.
Br. J. Dermatol.
151
,
328
-334.
Nava, P., Lopez, S., Arias, C. F., Islas, S. and Gonzalez-Mariscal, L. (
2004
). The rotavirus surface protein VP8 modulates the gate and fence function of tight junctions in epithelial cells.
J. Cell Sci
117
,
5509
-5519.
Nusrat, A., Turner, J. R. and Madara, J. L. (
2000
). Molecular physiology and pathophysiology of tight junctions. IV. regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells.
Am. J. Physiol. Gastrointest. Liver Physiol.
279
,
G851
-G857.
Osler, M. E., Chang, M. S. and Bader, D. M. (
2005
). Bves modulates epithelial integrity through an interaction at the tight junction.
J. Cell Sci.
118
,
4667
-4678.
Paris, L., Tonutti, L., Vannini, C. and Bazzoni, G. (
2008
). Structural organization of the tight junctions.
Biochim. Biophys. Acta
1778
,
646
-659.
Pritchard, D. M. and Crabtree, J. E. (
2006
). Helicobacter pylori and gastric cancer.
Curr. Opin. Gastroenterol.
22
,
620
-625.
Raschperger, E., Engstrom, U., Pettersson, R. F. and Fuxe, J. (
2004
). CLMP, a novel member of the CTX family and a new component of epithelial tight junctions.
J. Biol. Chem.
279
,
796
-804.
Resnick, M. B., Konkin, T., Routhier, J., Sabo, E. and Pricolo, V. E. (
2005
). Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study.
Mod. Pathol.
18
,
511
-518.
Riazuddin, S., Ahmed, Z. M., Fanning, A. S., Lagziel, A., Kitajiri, S., Ramzan, K., Khan, S. N., Chattaraj, P., Friedman, P. L., Anderson, J. M. et al. (
2006
). Tricellulin is a tight-junction protein necessary for hearing.
Am. J. Hum. Genet.
79
,
1040
-1051.
Richardson, C. and Alessi, D. R. (
2008
). The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway.
J. Cell Sci.
121
,
3293
-3304.
Roh, M. H., Liu, C. J., Laurinec, S. and Margolis, B. (
2002
). The carboxyl terminus of zona occludens-3 binds and recruits a mammalian homologue of discs lost to tight junctions.
J. Biol. Chem.
277
,
27501
-27509.
Roh, M. H., Fan, S., Liu, C. J. and Margolis, B. (
2003
). The Crumbs3-Pals1 complex participates in the establishment of polarity in mammalian epithelial cells.
J. Cell Sci.
116
,
2895
-2906.
Runswick, S., Mitchell, T., Davies, P., Robinson, C. and Garrod, D. R. (
2007
). Pollen proteolytic enzymes degrade tight junctions.
Respirology
12
,
834
-842.
Schneeberger, E. E. and Lynch, R. D. (
2004
). The tight junction: a multifunctional complex.
Am. J. Physiol.
286
,
C1213
-C1228.
Shen, L., Weber, C. R. and Turner, J. R. (
2008
). The tight junction protein complex undergoes rapid and continuous molecular remodeling at steady state.
J. Cell Biol.
181
,
683
-695.
Shin, K., Fogg, V. C. and Margolis, B. (
2006
). Tight junctions and cell polarity.
Annu. Rev. Cell Dev. Biol.
22
,
207
-235.
Simon, D. B., Lu, Y., Choate, K. A., Velazquez, H., Al-Sabban, E., Praga, M., Casari, G., Bettinelli, A., Colussi, G., Rodriguez-Soriano, J. et al. (
1999
). Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption.
Science
285
,
103
-106.
Sonoda, N., Furuse, M., Sasaki, H., Yonemura, S., Katahira, J., Horiguchi, Y. and Tsukita, S. (
1999
). Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier.
J. Cell Biol.
147
,
195
-204.
Sourisseau, T., Georgiadis, A., Tsapara, A., Ali, R. R., Pestell, R., Matter, K. and Balda, M. S. (
2006
). Regulation of PCNA and cyclin D1 expression and epithelial morphogenesis by the ZO-1-regulated transcription factor ZONAB/DbpA.
Mol. Cell. Biol.
26
,
2387
-2398.
Takai, E., Tan, X., Tamori, Y., Hirota, M., Egami, H. and Ogawa, M. (
2005
). Correlation of translocation of tight junction protein Zonula occludens-1 and activation of epidermal growth factor receptor in the regulation of invasion of pancreatic cancer cells.
Int. J. Oncol.
27
,
645
-651.
Tiwari-Woodruff, S. K., Buznikov, A. G., Vu, T. Q., Micevych, P. E., Chen, K., Kornblum, H. I. and Bronstein, J. M. (
2001
). OSP/claudin-11 forms a complex with a novel member of the tetraspanin super family and beta1 integrin and regulates proliferation and migration of oligodendrocytes.
J. Cell Biol.
153
,
295
-305.
Traweger, A., Fuchs, R., Krizbai, I. A., Weiger, T. M., Bauer, H. C. and Bauer, H. (
2003
). The tight junction protein ZO-2 localizes to the nucleus and interacts with the heterogeneous nuclear ribonucleoprotein scaffold attachment factor-B.
J. Biol. Chem.
278
,
2692
-2700.
Umeda, K., Ikenouchi, J., Katahira-Tayama, S., Furuse, K., Sasaki, H., Nakayama, M., Matsui, T., Tsukita, S. and Furuse, M. (
2006
). ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation.
Cell
126
,
741
-754.
Utech, M., Bruwer, M. and Nusrat, A. (
2006
). Tight junctions and cell-cell interactions.
Methods Mol. Biol.
341
,
185
-195.
Van Itallie, C. M. and Anderson, J. M. (
2006
). Claudins and epithelial paracellular transport.
Annu. Rev. Physiol.
68
,
403
-429.
Walters, R. W., Freimuth, P., Moninger, T. O., Ganske, I., Zabner, J. and Welsh, M. J. (
2002
). Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape.
Cell
110
,
789
-799.
Wan, H., Winton, H. L., Soeller, C., Tovey, E. R., Gruenert, D. C., Thompson, P. J., Stewart, G. A., Taylor, G. W., Garrod, D. R., Cannell, M. B. et al. (
1999
). Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions.
J. Clin. Invest.
104
,
123
-133.
Wang, Q. and Margolis, B. (
2007
). Apical junctional complexes and cell polarity.
Kidney Int.
72
,
1448
-1458.
Wang, Z., Mandell, K. J., Parkos, C. A., Mrsny, R. J. and Nusrat, A. (
2005
). The second loop of occludin is required for suppression of Raf1-induced tumor growth.
Oncogene
24
,
4412
-4420.
Weber, C., Fraemohs, L. and Dejana, E. (
2007
). The role of junctional adhesion molecules in vascular inflammation.
Nat. Rev. Immunol.
7
,
467
-477.
Wegmann, F., Ebnet, K., Du Pasquier, L., Vestweber, D. and Butz, S. (
2004
). Endothelial adhesion molecule ESAM binds directly to the multidomain adaptor MAGI-1 and recruits it to cell contacts.
Exp. Cell Res.
300
,
121
-133.
Wilcox, E. R., Burton, Q. L., Naz, S., Riazuddin, S., Smith, T. N., Ploplis, B., Belyantseva, I., Ben-Yosef, T., Liburd, N. A., Morell, R. J. et al. (
2001
). Mutations in the gene encoding tight junction claudin-14 cause autosomal recessive deafness DFNB29.
Cell
104
,
165
-172.
Wilson, F. H., Disse-Nicodeme, S., Choate, K. A., Ishikawa, K., Nelson-Williams, C., Desitter, I., Gunel, M., Milford, D. V., Lipkin, G. W., Achard, J. M. et al. (
2001
). Human hypertension caused by mutations in WNK kinases.
Science
293
,
1107
-1112.
Wu, X., Li, S., Chrostek-Grashoff, A., Czuchra, A., Meyer, H., Yurchenco, P. D. and Brakebusch, C. (
2007
). Cdc42 is crucial for the establishment of epithelial polarity during early mammalian development.
Dev. Dyn.
236
,
2767
-2778.
Xu, J., Kausalya, P. J., Phua, D. C., Ali, S. M., Hossain, Z. and Hunziker, W. (
2008
). Early embryonic lethality of mice lacking ZO-2, but Not ZO-3, reveals critical and nonredundant roles for individual zonula occludens proteins in mammalian development.
Mol. Cell. Biol.
28
,
1669
-1678.
Yamada, S. and Nelson, W. J. (
2007
). Synapses: sites of cell recognition, adhesion, and functional specification.
Annu. Rev. Biochem.
76
,
267
-294.
Yamauchi, K., Rai, T., Kobayashi, K., Sohara, E., Suzuki, T., Itoh, T., Suda, S., Hayama, A., Sasaki, S. and Uchida, S. (
2004
). Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins.
Proc. Natl. Acad. Sci. USA
101
,
4690
-4694.
Yeaman, C., Grindstaff, K. K. and Nelson, W. J. (
2004
). Mechanism of recruiting Sec6/8 (exocyst) complex to the apical junctional complex during polarization of epithelial cells.
J. Cell Sci.
117
,
559
-570.
Yu, A. L., McCarthy, K. M., Francis, S. A., McCormack, J. M., Lai, J., Rogers, R. A., Lynch, R. D. and Schneeberger, E. E. (
2005
). Knock down of occludin expression leads to diverse phenotypic alterations in epithelial cells.
Am. J. Physiol. Cell Physiol.
288
,
C1231
-C1241.